Pharmaceuticals in Russia

Publication Date	March 2009
Publisher	Datamonitor
Product Type	Report
Pages	32
ISBN Number	not applicable
Product Code	DAT03050

Buy this product or for assistance call +44 20 7060 7474

PDF £150.00$250 | €168

FAX Order above formats by FAX

Summary

Datamonitor's Pharmaceuticals in Russia industry profile is an essential resource for top-level data and analysis covering the Russia industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

Contains an executive summary and data on value, volume and/or segmentation
Provides textual analysis of the industry's recent performance and future prospects
Incorporates in-depth five forces competitive environment analysis and scorecards
Includes a five-year forecast of the industry
The leading companies are profiled with supporting key financial metrics
Supported by the key macroeconomic and demographic data affecting the market

Highlights

Detailed information is included on market size, measured by value and/or volume
Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
Market shares are covered by manufacturer or brand

Why you should buy this report

Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2007 annual average exchange rates.

The global figure comprises the Americas, Asia-Pacific and Europe.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Content

TABLE OF CONTENTS
EXECUTIVE SUMMARY
Chapter 1 Market Overview
- 1.1 Market Definition
- 1.2 Research Highlights
- 1.3 Market Analysis
Chapter 2 Market Value
CHAPTER 3 Market Segmentation I
CHAPTER 4 Market Segmentation II
Chapter 5 Market Share
Chapter 6 Five Forces Analysis
- 6.1 Summary
- 6.2 Buyer Power
- 6.3 Supplier Power
- 6.4 New Entrants
- 6.5 Substitutes
- 6.6 Rivalry
Chapter 7 Leading Companies
- 7.1 Novartis AG
- 7.2 Sanofi-Aventis SA
- 7.3 Menarini Group
Chapter 8 Market Forecasts
- 8.1 Market Value Forecast
Chapter 9 Macroeconomic Indicators
Chapter 1 Appendix
- 1.1 Methodology
- 1.2 Industry Associations
- 1.3 Related Datamonitor Research
LIST OF TABLES
- Table 1: Russia Pharmaceuticals Market Value: $ billion, 2004-2008
- Table 2: Russia Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
- Table 3: Russia Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
- Table 4: Russia Pharmaceuticals Market Share: % Share, by Value, 2008(e)
- Table 5: Key Facts: Novartis AG
- Table 6: Key Financials: Novartis AG
- Table 7: Key Facts: Sanofi-Aventis SA
- Table 8: Key Financials: Sanofi-Aventis SA
- Table 9: Key Facts: Menarini Group
- Table 10: Russia Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
- Table 11: Russia Size of Population (million) , 2004-2008
- Table 12: Russia GDP (Constant 2000 Prices, $ billion), 2004-2008
- Table 13: Russia Inflation, 2004-2008
- Table 14: Russia Exchange Rate, 2004-2008